Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Chin J Nat Med ; 12(6): 428-35, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24969523

RESUMO

AIM: To investigate the cytotoxic effects of the six protoberberine alkaloids (PAs) from Rhizoma Coptidis on HepG2 cells. METHOD: A systematic screening was conducted to investigate the dynamic response of HepG2 cells to the PAs using the impedance-based xCELLigence system. Cisplatin was selected as the positive control. The real time, concentration-response curves and the 50% inhibitory concentrations (IC50) were acquired to evaluate the anticancer activity of the PAs. RESULTS: All of the six PAs inhibited cell growth and induce death in HepG2 cells in a time- and concentration-dependent manner. The IC50 values of cisplatin, berberine, columbamine, coptisine, epiberberine, jatrorrhizine, and palmatine were 5.13, 42.33, 226.54, 36.90, 302.72, 383.54, and 456.96 µg·mL(-1), respectively. The results obtained using the xCELLigence system corresponded well with those of the conventional methods. CONCLUSION: The xCELLigence system is a reliable and efficient tool for real-time screening of the cytotoxic effect of compounds in cell-based in vitro assays. Coptisine and berberine, with methylenedioxy group at C2 and C3 on the phenyl ring showed stronger effect.than the other four PAs. However, compared with cisplatin, the six PAs didn't show obvious cytotoxic effect on HepG2 cells. These results provided some useful data for the evaluation of the anticancer compounds, and the clinical application of traditional Chinese medicine.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Alcaloides de Berberina/farmacologia , Coptis/química , Medicamentos de Ervas Chinesas/farmacologia , Hepatoblastoma/fisiopatologia , Neoplasias Hepáticas/fisiopatologia , Fitoterapia , Antineoplásicos Fitogênicos/uso terapêutico , Berberina/análogos & derivados , Berberina/farmacologia , Berberina/uso terapêutico , Alcaloides de Berberina/uso terapêutico , Morte Celular/efeitos dos fármacos , Cisplatino/farmacologia , Cisplatino/uso terapêutico , Avaliação Pré-Clínica de Medicamentos/métodos , Medicamentos de Ervas Chinesas/uso terapêutico , Impedância Elétrica , Células Hep G2 , Hepatoblastoma/tratamento farmacológico , Humanos , Concentração Inibidora 50 , Neoplasias Hepáticas/tratamento farmacológico , Rizoma/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA